| Autor: |
Bedimo RJ; Department of Medicine, VA North Texas Health Care System, Dallas (R.J.B.).; Department of Medicine, University of Texas Southwestern Medical Center at Dallas (R.J.B., F.S.)., Strasserking F; Department of Medicine, University of Texas Southwestern Medical Center at Dallas (R.J.B., F.S.)., Tebas P; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia (P.T.). |
| Jazyk: |
angličtina |
| Zdroj: |
Circulation [Circulation] 2024 May 07; Vol. 149 (19), pp. 1471-1473. Date of Electronic Publication: 2024 May 06. |
| DOI: |
10.1161/CIRCULATIONAHA.123.065836 |
| Abstrakt: |
Competing Interests: Disclosures R.J.B. reported receiving research grants/grants pending awarded to his institution from Merck & Co, Inc, and serving on the scientific advisory board for Merck & Co, Inc, ViiV Healthcare, Gilead Sciences, Inc, Shionogi, and Janssen Pharmaceuticals. P.T. has received compensation for consultation services from Merck, Gilead, and ViiV Healthcare. Additionally, the University of Pennsylvania has been granted financial support in the form of research grants for conducting HIV-related studies from the National Institutes of Health, Merck, Gilead, ViiV Healthcare, Sangamo, Takeda and Janssen Pharmaceuticals. The other author reports no conflicts. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
